The purpose of this study was to determine the effects of manual metal arc stainless steel welding fume particulates (MMA-SS) on the immune system. MMA-SS (Lincoln Electric Co., Cleveland, OH) were determined to consist of Fe and Ni in the insoluble portion, with Cr and Mn in the soluble portion. Total, soluble, and insoluble MMA-SS particulate were directly exposed to splenocytes derived from female B6C3F1 mice. Viability studies identified the EC50 value to be 6.4 ug/ml; MMA-SS concentrations of 5, 2.5 and 1.25 ug/ml were used for experiments. Significant decreases in the total IgM (antibody response to sRBC)/106 viable cells (87%, 67%) and total IgM/well (73%, 58%) was observed in the splenocytes exposed to 5 ug/ml of total and soluble MMA-SS welding fumes, respectively. Female B6C3F1 mice were administered MMA-SS by pharyngeal aspiration every 5 days over a 20 day period at concentrations of 10 mg/kg and 20 mg/kg with no observed changes in body weight and a 32% (p < 0.05) increase in lung weight. A dose dependent decrease in the number of AFC/106 cells and AFC/spleen in response to i.v. immunization with sRBC were observed after pretreatment with MMA-SS. The specific activity (IgM AFC/106 spleen cells) was decreased 18 and 33% following exposure of mice to 10 or 20 mg/kg respectively. A decrease in AFC/lung associated lymph nodes (LALN) was also observed in response to i.t. immunization with sRBC after exposure to MMA-SS. There was a 75% (p < 0.01) and 42% (p < 0.05) decrease in AFC /LALN after exposure to 20 mg/kg and 10 mg/kg, respectively. The immunosuppressive effects seen may be caused by the direct release of soluble MMA-SS metals or indirect actions mediated via the hypothalamic pituitary axis or due to the local inflammatory process.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.